Table 4.
Distribution of prescribed anti-infectives; by groups, subgroups and ATC codes; in a Teaching and a Non-teaching hospital in Ujjain district, India
|
Antibiotics groups/subgroups with ATC codes |
Teaching hospital |
Non-teaching hospital |
|
|---|---|---|---|
| n (%) | n (%) | ||
|
Total prescribing occasions |
|
30311 (100) |
35534 (100) |
|
ANTIBACTERIALS FOR SYSTEMIC USE; J01 |
|
25867 (85.3) |
35427 (99.7) |
|
Tetracyclines; J01A |
Tetracyclines; J01AA |
2235 (7.4) |
94 (0.2) |
|
Amphenicols; J01B |
Amphenicols; J01BA |
40 (0.1) |
0 (0.0) |
|
β- lactam antibiotics, penicillin; J01C |
|
3100 (10.2) |
3268 (9.8) |
| |
Penicillins with extended spectrum; J01CA |
778 (2.6) |
808 (2.3) |
| |
Beta-lactamase sensitive penicillins; J01CE |
3 (0.0) |
18 (0.0) |
| |
Beta-lactamase inhibitors; J01CG |
5 (0.0) |
2 (0.0) |
| |
Combination of penicillin including beta lactamase antibiotics; J01CR |
2314 (7.6) |
2440 (7.4) |
|
Other beta lactam; J01D |
|
4333 (14.3) |
11929 (33.3) |
| |
1st generation Cephalosporins; J01DB |
645 (2.1) |
135 (0.4) |
| |
2nd generation Cephalosporins; J01DC |
2 (0.0) |
516 (1.4) |
| |
3rd generation Cephalosporins; J01DD |
3686 (12.2) |
11174 (31.3) |
| |
Fourth-generation Cephalosporins; J01DE |
0 (0.0) |
51 (0.1) |
| |
Carbapenems J01DH |
0 (0.0) |
53 (0.1) |
|
Sulfonamide with Trimethoprim; J01E |
Combination of Sulfonamide with Trimethoprim; J01EE |
928 (3.1) |
6 (0.01) |
|
Macrolides, lincosamides; J01F |
|
842 (2.8) |
150 (0.6) |
| |
Macrolides; J01FA |
58 (0.2) |
78 (0.3) |
| |
Lincosamides; J01FF |
784 (2.6) |
72 (0.3) |
|
Aminoglycoside; J01G |
|
4068 (13.4) |
3484 (10.2) |
| |
Streptomycin; J01GA |
212 (0.7) |
4 (0.0) |
| |
Other Aminogylcosides; J01GB |
3856 (12.7) |
3480 (10.2) |
|
Quinolones; J01M |
Fluoroquinolones; J01MA |
6887 (22.7) |
4156 (11.7) |
|
Combination of antibiotics; *J01R |
Combination of Antibiotics; *J01RA |
1194 (3.9) |
9084 (25.1) |
|
Other antibiotics; J01X |
|
2240 (7.4) |
3256 (8.8) |
| |
Glycopeptide antibacterials; J01XA |
6 (0.0) |
16 (0.0) |
| |
Imidazole derivatives; J01XD |
2216 (7.3) |
3173 (8.6) |
| |
Nitrofurantoin; J01XE |
18 (0.1) |
5 (0.0) |
| |
Other antibacterials; J01XX |
0 (0.0) |
62 (0.2) |
|
DRUGS FOR TREATMENT OF TUBERCULOSIS; J04 |
|
2257 (7.5) |
7 (0.02) |
|
Drugs for treatment of Tuberculosis; J04A |
|
|
|
| |
Antibiotics; J04AB |
574 (1.9) |
7 (0.02) |
| |
Hydrazides; J04AC |
570 (1.9) |
0 (0.0) |
| |
Other drugs for treatment of tuberculosis; J04AK |
1113 (3.7) |
0 (0.0) |
|
AGENTS AGAINST AMOEBIASIS & OTHER PROTOZOAL DISEASES P01; |
|
2187 (7.2) |
100 (0.3) |
|
Agents against amoebiasis & protozoal diseases; P01A |
|
|
|
| |
Nitroimidazole derivatives; P01AB |
2187 (7.2) |
95 (0.3) |
| Other agents against amoebiasis & other protozoal diseases; P01AX | 0 (0.0) | 5 (0.01) | |
n (%): Absolute number of prescribing occasions (percentage of total prescribing occasions).